Cancer

HELP ACCELERATE RESEARCH FOR

Cancer

Study Name:

Cancer Research Study

location

Location: San Diego, CA

compensation

Compensation: $100

length

Length: 30 minutes

The goal of this research is to allow researchers to enhance our understanding of cancer, in support of developing new diagnostic and treatment options for patients living with cancer.

You can participate if you:

  • Are 18 to 85 years of age 
  • Are diagnosed with cancer

 

You cannot participate if you:

  • Are pregnant
  • Have an infectious disease, such as active HIV, hepatitis, or other infectious diseases
  • Experienced excess blood loss including blood donation defined as 250 mL in the last month or 500 mL in the last two months

How the Donation Process Works

Screening

Once you have signed up to participate in the research study, an onsite or remote coordinator will conduct a screening that will take about 15 minutes. 

During the screen, you will be asked questions about your health and demographic information related to the specific study.

screening
Informed-Consent-and-Documentation

Informed Consent and Documentation

Once you are confirmed eligible to participate in a study, you will be required to complete an electronic Informed Consent Form (ICF) and Medical Record Authorization (MRA).

Informed Consent is the most important aspect of any research study as it outlines and confirms research participants’ rights.

Medical Record Authorization ensures you meet all the study requirements and confirms it is safe for you to participate.

Appointment

After all proper documentation is on file, we will schedule your blood collection with a trained phlebotomist remotely or at the site.

Please make sure to be well hydrated on the day of your appointment and follow all instructions provided.

Appointment

About Sanguine

We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research from home. Our goal is to develop innovative solutions that empower patients to participate in research for conditions that matter most to them, regardless of their location or ability to travel.

We work directly with patients and advocacy groups to accelerate research through convenience and transparency while guiding each patient every step of the way.

Have a question?

Sanguine is partnering with a biopharma company that is trying to develop novel immunotherapies using patients' immune cells to target ovarian cancer.

The informed consent form details how participant's donated sample and data will be used and outlines any risks associated. Also explains compensation and future participation protocol.

Medical records are used to enroll participants in future studies and provide redacted data summarizes to biopharma clients

If a participants earn more than $600 in compensation within a calendar year, the IRS will require them to fill out a 1090 form

Participants will be compensated by receiving an electronic gift card via email within 24 hours of the collection taking place. At an additional cost there is also an option to receive a physical card shipped directly to participant

Yes, Sanguine will compensate a participant if there is an attempt at collecting biospecimen

Sanguine Biosciences speeds up medical discoveries by providing high-quality biospecimens for therapeutic and diagnostic research. Using a direct-to-donor model, we make it easy for people to participate in research—often from the comfort of their homes. This ensures researchers receive high-quality samples along with detailed donor data, helping advance scientific breakthroughs faster.

Sanguine does not provide participants with sample data however, the biopharma client may publish a research paper or publication

Sanguine assigns every participant a unique patient ID number that can only be tracked internally. Sanguine does not provide any patient identifying information to clients and all medical records are redacted.

Due to this research study being involved in early stages of drug development, the client is unable to openly share their information

Fasting is not required in order to participate. We suggest participants are well hydrated and have a meal prior to donating

questions@2x